DIANTHUS THERAPEUTICS

DIANTHUS THERAPEUTICS Share · US2528281080 · DNTH · A3ERZ4 (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of DIANTHUS THERAPEUTICS
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
1
9
0
0
0
No Price
01.05.2026 20:00
Current Prices from DIANTHUS THERAPEUTICS
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DNTH
USD
01.05.2026 20:00
87,42 USD
-0,38 USD
-0,43 %
IEXG: IEX
IEX
DNTH
USD
01.05.2026 19:59
87,31 USD
-0,49 USD
-0,56 %
XDUS: Düsseldorf
Düsseldorf
DTIRSN80.DUSB
EUR
30.04.2026 17:32
73,00 EUR
-1,00 EUR
-1,35 %
XDQU: Quotrix
Quotrix
DTIRSN80.DUSD
EUR
30.04.2026 05:27
71,50 EUR
-
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 69,84 %
Shares Float 26,83 M
Shares Outstanding 38,42 M
Company Profile for DIANTHUS THERAPEUTICS Share
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.

Company Data

Name DIANTHUS THERAPEUTICS
Company Dianthus Therapeutics, Inc.
Symbol DNTH
Website https://dianthustx.com
Primary Exchange XNCM Frankfurt
WKN A3ERZ4
ISIN US2528281080
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Marino Garcia
Market Capitalization 3 Mrd.
Country United States of America
Currency EUR
Employees 0,1 T
Address 7 Times Square, 10036 New York City
IPO Date 2018-06-21

Stock Splits

Date Split
12.09.2023 1:16

ID Changes

Date From To
12.09.2023 MGTA DNTH

Ticker Symbols

Name Symbol
Düsseldorf DTIRSN80.DUSB
Frankfurt 87E.F
NASDAQ DNTH
Quotrix DTIRSN80.DUSD
More Shares
Investors who hold DIANTHUS THERAPEUTICS also have the following shares in their portfolio:
DIREXION DAILY 10-YR TREASURY BULL 3X SHRS
DIREXION DAILY 10-YR TREASURY BULL 3X SHRS ETF
PEN/CAD CANADIAN DOLLAR
PEN/CAD CANADIAN DOLLAR Currency